11th Circ. Denies Cert. Appeal In $867M Astellas Antitrust Suit

11th Circ. Denies Cert. Appeal In $867M Astellas Antitrust Suit

The 11th Circuit refused Thursday to let a Florida hospital appeal in hopes of winning certification of an $867 million antitrust class action accusing Astellas Pharma Inc. of improperly requiring use of its Adenoscan drug with patented cardiac tests ...read more

  • Tags: